Tumor matrix stiffness provides fertile soil for cancer stem cells
S Safaei, R Sajed, A Shariftabrizi, S Dorafshan… - Cancer cell …, 2023 - Springer
Matrix stiffness is a mechanical characteristic of the extracellular matrix (ECM) that increases
from the tumor core to the tumor periphery in a gradient pattern in a variety of solid tumors …
from the tumor core to the tumor periphery in a gradient pattern in a variety of solid tumors …
Unraveling the tumor microenvironment: insights into cancer metastasis and therapeutic strategies
This comprehensive review delves into the pivotal role of the tumor microenvironment (TME)
in cancer metastasis and therapeutic response, offering fresh insights into the intricate …
in cancer metastasis and therapeutic response, offering fresh insights into the intricate …
Crosstalk between PD-L1 and Jak2-Stat3/MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance
Background Programmed cell death ligand-1 (PD-L1) is an antitumor immunity molecule
and a great target to cure oral cancer; nonetheless, the limited success can be attributed to …
and a great target to cure oral cancer; nonetheless, the limited success can be attributed to …
Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization
J Fierro Jr, J DiPasquale, J Perez, B Chin… - Scientific Reports, 2022 - nature.com
Programmed death ligand 1 (PD-L1) plays a key role in glioblastoma multiforme (GBM)
immunosuppression, vitality, proliferation, and migration, and is therefore a promising target …
immunosuppression, vitality, proliferation, and migration, and is therefore a promising target …
Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer
Y Yang, L Xia, Y Wu, H Zhou, X Chen… - Cancer …, 2021 - Wiley Online Library
Background Although programmed cell death‐ligand 1 (PD‐L1) plays a well‐known function
in immune checkpoint response by interacting with programmed cell death‐1 (PD‐1), the …
in immune checkpoint response by interacting with programmed cell death‐1 (PD‐1), the …
EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells
X Shen, X Jin, S Fang, J Chen - Cellular & Molecular Biology Letters, 2023 - Springer
Background Fibulin-like extracellular matrix protein 2 (EFEMP2) has been reported to be
related to the progression of various cancers. We have previously reported that EFEMP2 …
related to the progression of various cancers. We have previously reported that EFEMP2 …
HOXA‐AS3 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells via the miR‐455‐5p/PD‐L1 Axis
C Zeng, S Ye, Y Chen, Q Zhang, Y Luo… - Journal of …, 2021 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the most prevalent type of hepatic carcinoma. Long
noncoding RNAs (lncRNAs) are considered crucial regulators of gene expression; however …
noncoding RNAs (lncRNAs) are considered crucial regulators of gene expression; however …
Fat mass and obesity‐associated protein regulates arecoline‐exposed oral cancer immune response through programmed cell death‐ligand 1
X Li, W Chen, Y Gao, J Song, Y Gu, J Zhang… - Cancer …, 2022 - Wiley Online Library
The high prevalence of oral squamous cell carcinoma (OSCC) in South Asia is associated
with habitual areca nut chewing. Arecoline, a primary active carcinogen within areca nut …
with habitual areca nut chewing. Arecoline, a primary active carcinogen within areca nut …
E3 ubiquitin ligase RNF125 suppresses immune escape in head and neck squamous cell carcinoma by regulating PD-L1 expression
C Jiang, L He, S Xiao, W Wu, Q Zhao, F Liu - Molecular Biotechnology, 2023 - Springer
Head and neck squamous cell carcinoma (HNSCC) is a lethal malignancy. Given the
essential roles of E3 ligases in cancer immunotherapies, this paper explored the effect of E3 …
essential roles of E3 ligases in cancer immunotherapies, this paper explored the effect of E3 …
PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway
F Wang, L Yang, M Xiao, Z Zhang, J Shen… - Scientific reports, 2022 - nature.com
As immune checkpoint inhibitors (ICIs) continue to advance, more evidence has emerged
that anti-PD-1/PD-L1 immunotherapy is an effective treatment against cancers. Known as …
that anti-PD-1/PD-L1 immunotherapy is an effective treatment against cancers. Known as …